BioMedTech Horizons

Banner Image

Round 3 applications are now open


Delivered by MTPConnect, the Australian Government's $45 million BioMedTech Horizons program is an initiative to support innovative collaborative health technologies, drive discoveries towards proof-of-concept and commercialisation that address key health challenges as well as maximise entrepreneurship and idea potential.  

Expressions of interest are now open for the third tranche of funding, with grants of up to $1 million available for medical device projects targeting innovative solutions to address unmet clinical needs in three key focus areas:

  • Digitally enabled medical devices in mobile health, health information technology, wearable devices, telehealth and telemedicine, and digitally enabled personalised medicine
  • Digitally enabled implantable medical devices addressing unmet needs in any therapeutic area
  • General medical devices in the areas of regenerative medicine, women’s health, cardiovascular, orthopaedics, neuroscience, general surgery and oncology

This funding, BMTH3.0, is delivered via the Medical Research Future Fund (MRFF), and administered by MTPConnect, the Medical Technology and Pharmaceutical Industry Growth Centre.

Investments from the program are focused on funding proof-of-concept to commercial development of biomedical and medical technologies (biomedtech).

Contact Director BioMedTech Horizons Vishal Srivastava on 03 9905 1754 for more information.

Round 2 applications are now closed

Applications for Round Two, which closed in July this year, have been shortlisted with funding announcements to be made before the end of 2019.

Sign up to the MTPConnect network to stay up to date with future funding opportunities and news.